Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.38 |
| ▸ | TLR2 | O60603 | 5/20 | 0.37 |
| ▸ | TACR1 | P25103 | 1/20 | 0.36 |
| ▸ | MRGPRX1 | Q96LB2 | 1/20 | 0.36 |
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.35 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.35 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.35 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.35 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.35 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.35 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11298010 | 0.88 | FFAR1 (0.41) | FFAR1TACR1CNR1CNR2MRGPRX4 | |
| SCHEMBL30515139 | 0.88 | PLA2G2A (0.43) | FFAR1TLR2TACR1MRGPRX1CNR1 | |
| SCHEMBL30515123 | 0.84 | FFAR1 (0.41) | FFAR1TLR2CNR1CNR2MAOB | |
| SCHEMBL11304595 | 0.82 | PLA2G2A (0.46) | FFAR1TLR2PLA2G4BPLA2G10PLA2G2A | |
| SCHEMBL31069869 | 0.80 | ALDH1A1 (0.34) | FFAR1TLR2TACR1MAOBPLA2G10 | |
| SCHEMBL25336781 | 0.79 | LPAR3 (0.56) | FFAR1 | |
| SCHEMBL25336782 | 0.79 | LPAR3 (0.56) | FFAR1 | |
| SCHEMBL29193334 | 0.77 | CTSG (0.32) | MRGPRX4 | |
| SCHEMBL29193148 | 0.77 | CTSG (0.32) | MRGPRX4 | |
| SCHEMBL29193149 | 0.77 | CTSG (0.32) | MRGPRX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118591377-A | Antiviral prodrugs, intermediate and long acting formulations and methods | 加利福尼亚大学董事会 | 2024-09-03 | — | — | CN | disclosed |